Clinical Trial Detail

NCT ID NCT03271047
Title Study of Binimetinib + Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Microsatellite-stable (MSS) Metastatic Colorectal Cancer With RAS Mutation
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Array BioPharma
Indications

colorectal cancer

Therapies

Binimetinib + Ipilimumab + Nivolumab

Binimetinib + Nivolumab

Age Groups: adult senior

No variant requirements are available.